LPCN:NASDAQ
Lipocine Inc
$2.22
arrow_downward
-1.33%(-0.030) 1D
Sep 14, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LPCN...
Open
$2.20
High
$2.27
Low
$2.15
Mkt. cap
18.30M
Avg. vol.
34.98K
Volume
27.32K
52-wk high
$12.37
52-wk low
$1.81
EPS
-$1.87
Beta
0.47
Shares outstanding
8.24M
No. of employees
14
Open
$2.20
High
$2.27
Low
$2.15
Mkt. cap
18.30M
Avg. vol.
34.98K
Volume
27.32K
52-wk high
$12.37
52-wk low
$1.81
EPS
-$1.87
Beta
0.47
Shares outstanding
8.24M
No. of employees
14
News stories
From web sources and news partners
Investing.com Australia
·
13 hours ago
Form 8K Lipocine Inc For: 14 September By Investing.com
Investing.com
·
14 hours ago
Lipocine initiates phase 3 trial for postpartum depression drug
PR Newswire
·
15 hours ago
Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression
TipRanks
·
15 hours ago
Lipocine Launches Phase 3 BLOOM Study for PPD
About Lipocine Inc
CEO-
Employees14
Founded1997
HeadquartersSalt Lake City, Utah, United States
SectorPharmaceutical industry
Websitelipocine.com